The Association between Monocyte Surface CD163 and Insulin Resistance in Patients with Type 2 Diabetes
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Association between Monocyte Surface CD163 and Insulin Resistance in Patients with Type 2 Diabetes
Authors
Keywords
-
Journal
Journal of Diabetes Research
Volume 2017, Issue -, Pages 1-8
Publisher
Hindawi Limited
Online
2017-12-29
DOI
10.1155/2017/6549242
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effects of DHA-enriched fish oil on monocyte/macrophage activation marker sCD163, asymmetric dimethyl arginine, and insulin resistance in type 2 diabetic patients
- (2016) Omid Toupchian et al. Journal of Clinical Lipidology
- Monocyte CD163 is altered in association with diabetic complications: possible protective role
- (2016) Danqing Min et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Loss of CCR2 expressing non-classical monocytes are associated with cognitive impairment in antiretroviral therapy-naïve HIV-infected Thais
- (2015) Lishomwa C. Ndhlovu et al. JOURNAL OF NEUROIMMUNOLOGY
- Visceral obesity is associated with increased soluble CD163 concentration in men with type 2 diabetes mellitus
- (2015) L. P. Sorensen et al. Endocrine Connections
- Soluble CD163 Is Associated With CD163 mRNA Expression in Adipose Tissue and With Insulin Sensitivity in Steady-State Condition but Not in Response to Calorie Restriction
- (2014) Jana Kračmerová et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Macrophage subsets in atherosclerosis
- (2014) Giulia Chinetti-Gbaguidi et al. Nature Reviews Cardiology
- Standards of Medical Care in Diabetes--2014
- (2013) DIABETES CARE
- The Haptoglobin-CD163-Heme Oxygenase-1 Pathway for Hemoglobin Scavenging
- (2013) Jens Haugbølle Thomsen et al. Oxidative Medicine and Cellular Longevity
- CD163 and Inflammation: Biological, Diagnostic, and Therapeutic Aspects
- (2012) Anders Etzerodt et al. ANTIOXIDANTS & REDOX SIGNALING
- Soluble CD163: a biomarker linking macrophages and insulin resistance
- (2012) T. Parkner et al. DIABETOLOGIA
- Clinical Impact of the Leptin to Soluble Leptin Receptor Ratio on Subclinical Carotid Atherosclerosis in Patients with Type 2 Diabetes
- (2012) Yuko Yamazaki et al. Journal of Atherosclerosis and Thrombosis
- Relationship between monocyte/macrophage activation marker soluble CD163 and insulin resistance in obese and normal-weight subjects
- (2011) Markella V. Zanni et al. CLINICAL ENDOCRINOLOGY
- In vitro and in vivo evidence for the role of elastase shedding of CD163 in human atherothrombosis
- (2011) Juan Antonio Moreno et al. EUROPEAN HEART JOURNAL
- CD163 and its role in inflammation
- (2011) Krzysztof Kowal et al. FOLIA HISTOCHEMICA ET CYTOBIOLOGICA
- Soluble CD163
- (2011) Holger J. Møller SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION
- Serum Soluble CD163 Predicts Risk of Type 2 Diabetes in the General Population
- (2010) H. J. Moller et al. CLINICAL CHEMISTRY
- Tumor necrosis factor α-converting enzyme (TACE/ADAM17) mediates ectodomain shedding of the scavenger receptor CD163
- (2010) Anders Etzerodt et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Enhanced frequencies of CD14++CD16+, but not CD14+CD16+, peripheral blood monocytes in severe asthmatic patients
- (2008) Marcin Moniuszko et al. CLINICAL IMMUNOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now